Open Access Critical Evidence Review

Three glycemic measures and mortality risk: a prospective cohort study

The study observes that, in U.S. adults not on antidiabetic therapy, elevated glycemia two hours after an oral glucose tolerance test signals total and cardiovascular mortality. Independent literature confirms a more robust prognostic association for post-load glycemia compared to fasting, but does not demonstrate causality or superiority in many clinical settings.

Cite this article
Moscati, M. (2026). Three glycemic measures and mortality risk: a prospective cohort study. Life Science Hub Journal. DOI: 10.5281/zenodo.24256176. https://lifesciencehub.info/en/three-glycemic-measures-and-mortality-risk-a-prospective-cohort-study
LIFE Science Hub - Journal of Science · 2026 / Nov

DOI 10.5281/zenodo.24256176

Article history
Dates
  • Published 12/11/2026
  • Updated 15/11/2026
Revisions
  1. v1.0 — 12/11/2026 Initial publication of the article.
  2. v1.1 — 15/11/2026 Editorial update of content, sources or references.

LIFE Science Hub keeps a record of every published version of the article to ensure editorial transparency. Future revisions will appear here.

Laboratory still-life with a test tube, an OGTT glass, and an hourglass, evoking the two-hour glycemia and cardiometabolic risk.
A blood test tube, an OGTT glass, and blurred charts in the background evoke the two-hour glycemic response and its prognostic value.

ABSTRACT

The study analyzed compared fasting glycemia, glycated hemoglobin (HbA1c, an indicator of average glucose exposure over the last few months), and plasma glucose two hours after an oral glucose tolerance test (2hPG). In 14,013 US adults not treated with antidiabetic drugs, followed for a median of 9.8 years, elevated values of all three markers were associated with higher total and cardiovascular mortality when evaluated separately.

The publication contributes to the narrative of "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, according to which the glucose tolerance test can reveal alterations not fully visible while fasting. Independent studies in European, elderly US, and Chinese cohorts confirm that a higher 2hPG is associated with an increased risk of mortality and cardiovascular events, even when considering other glycemic markers. However, this is observational prognostic evidence: the test identifies a risk profile, but it does not prove that reducing post-load glycemia in isolation reduces mortality.

Analyzed study

Associations of three diagnostic glycemic measures with all-cause and cardiovascular mortality in people not on antidiabetic medications: A prospective cohort study

Zhang J, Zheng W, Wang S, Gao X, Xiao Y, Yang Z

Journal of diabetes and its complications, 2025

DOI: 10.1016/j.jdiacomp.2025.108970

PMID: 39908967

The research question was whether three tests used to identify diabetes or elevated glycemia—fasting glycemia, HbA1c, and glycemia measured two hours after 75 grams of glucose—provided independent prognostic information on all-cause and cardiovascular mortality. The hypothesis was that each marker might maintain, or lose, its ability to signal risk when considered alongside the other two.

The relevance to the book's section is precise. The publication subject to the Evidence Review does not directly measure insulin secretion, muscle sensitivity to insulin, or glucose production by the liver. Instead, it documents the prognostic segment of the narrative: elevated glycemia two hours after a glucose load may contain information about future risk that is not entirely overlapping with that of fasting glycemia and HbA1c.

As a prospective cohort study, it can show that a glycemic value precedes and is associated with an outcome over time. It cannot establish that post-load glycemia is the cause of mortality, nor can it demonstrate that the test is necessarily the best examination for every person or in every clinical context.

Materials and methods of the original study

The authors identified 14,013 U.S. adults from NHANES III and NHANES 2005-2016 who were not taking antidiabetic medication at the time of recruitment. NHANES is a program of health surveys of the U.S. population. The design was a prospective cohort: participants were classified based on initial examinations and then followed over time to track deaths.

Elevated glycemia was defined according to the 2023 American Diabetes Association standards: 2hPG equal to or greater than 11.1 mmol/L, fasting glycemia equal to or greater than 7.0 mmol/L, or HbA1c equal to or greater than 6.5%. The authors adopted two strategies. In the first, they included all three glycemic markers simultaneously in the statistical models; in the second, they compared people with an isolated increase in only one of the three markers with people who were normal for all three.

Multivariate analyses accounted for the main non-glycemic risk factors. The available material does not report the complete list of adjustment variables, detailed exclusion criteria, methods for ascertaining deaths, the number of participants in each glycemic group, or the technical details of the statistical analyses.

Results

During a median follow-up of 9.8 years, 2,869 participants died; 960 deaths were attributed to cardiovascular causes. Considered one at a time, elevated 2hPG, elevated fasting glycemia, and elevated HbA1c were all linked to higher total and cardiovascular mortality. The adjusted hazard ratios—that is, the ratios between the rates at which death occurs in the compared groups—ranged from 1.32 to 1.55. In practical terms, these values correspond to a higher frequency of death in the groups with elevated glycemia compared to the reference groups.

The available abstract also reports that the authors evaluated the three tests in the same model and analyzed isolated elevations. However, the provided abstract text cuts off before reporting the complete estimates for these analyses. Therefore, the specific hazard ratios, confidence intervals, P-values, and the exact details of the simultaneous comparison between 2hPG, fasting glycemia, and HbA1c are not reported in the available material.

The central data point relevant to the book is therefore that the two-hour post-load glycemia was studied not only as a diagnostic criterion but as a possible prognostic indicator distinct from the other two main glycemic markers. However, the accessible data do not allow for a direct, precise quantification of how much its independent value was greater compared to the other tests.

Interpretation

In simple terms, fasting glycemia provides a snapshot of the body in a relatively stable condition, while 2hPG observes how much glucose remains in the blood after a standardized challenge. If the value remains high after two hours, the body has managed the glucose load less effectively.

This response depends on several functions simultaneously: the beta cells of the pancreas must release insulin adequately; muscles and adipose tissue must respond to the insulin signal and remove glucose from the blood; the liver must reduce its own glucose production. The test does not measure each of these steps separately, but the final glycemia can reflect the overall result of their interaction.

The transition documented by the analyzed study is therefore prognostic: an elevated 2hPG identifies individuals with higher observed mortality over time. The pathophysiological interpretation proposed in the book is biologically plausible, but it is not directly proven by this cohort because insulin levels, measures of beta-cell function, or direct insulin sensitivity tests were not reported.

Independent confirming evidence

Historical confirmation comes from the European DECODE project, which brought together 13 prospective cohorts with 25,364 adults aged 30 or older and a mean follow-up of 7.3 years. Within the same fasting glycemia categories, mortality increased as the two-hour glycemia rose. Conversely, in the categories of impaired glucose tolerance or diabetes defined by 2hPG, no similar gradual increase in mortality emerged with increasing fasting glycemia. For impaired glucose tolerance, the hazard ratio for mortality was 1.51 in men and 1.60 in women compared to their respective groups with normal values. This directly supports the book's assertion that the OGTT can add prognostic information compared to the baseline value alone [1].

A second confirmation comes from the Cardiovascular Health Study, a prospective cohort of 2,394 elderly Americans without treated diabetes, with a mean age of 78 and a median follow-up of 11.2 years. After adjustment for clinical factors and fasting glycemia, each one-standard-deviation increase in 2hPG remained associated with a 12% increase in all-cause mortality; hazard ratio 1.12, 95% confidence interval from 1.04 to 1.19. In the same model, the association of fasting glycemia with mortality did not remain statistically significant. The study confirms the direction of the association, but it primarily concerns elderly individuals and does not demonstrate a causal effect of post-load glycemia [2].

In a large Chinese cohort of 193,846 adults aged at least 40, followed for up to five years, untreated diabetes defined by a 2hPG of 200 mg/dL or higher was associated with higher all-cause mortality, with a hazard ratio of 1.57 and a 95% confidence interval from 1.41 to 1.76. The corresponding associations with diabetes defined by fasting glycemia and HbA1c were 1.37 and 1.33, respectively. Furthermore, 2hPG remained associated with outcomes in models that also included the other two markers and statistically improved the model's predictive capacity. This extends the confirmation to a population very different from the American one, while maintaining the inherent limitations of an observational study [3].

Conflicting evidence

No directly conflicting evidence of sufficient relevance has been identified; this does not prove the absence of contrary results.

However, there are limitations that reduce the possibility of considering 2hPG universally superior. The three markers do not represent exactly the same biological phenomenon, and their utility may vary with age, population origin, prevalence of undiagnosed diabetes, pre-analytical conditions, and clinical objective. Even when 2hPG is more strongly associated with mortality, the increase in absolute predictive capacity compared to already available clinical models may be modest. Furthermore, a prognostic association does not prove that selectively intervening on post-load glycemia changes cardiovascular outcomes or survival.

Summary table of evidence

The table distinguishes the publication subject to the review from independent research that confirms the specific narrative of the book's paragraph.

Reference Study type Population or model Main result Direction of evidence Strength of evidence
Original study Prospective cohort 14,013 US adults not on antidiabetic medication Elevated 2hPG, fasting glycemia, and HbA1c were associated with higher mortality when assessed separately; complete estimates from simultaneous models are not available in the provided abstract. biologically consistent evidence moderate
[1] Joint analysis of prospective cohorts 25,364 European adults, 13 cohorts Mortality increased with 2hPG within fasting glycemia categories; fasting alone did not fully identify risk. direct confirmation high
[2] Prospective cohort 2,394 US elderly without treated diabetes Higher 2hPG remained associated with increased mortality and cardiovascular disease after adjustment for fasting glycemia. direct confirmation moderate
[3] Prospective cohort 193,846 Chinese adults aged 40 or older Diabetes defined by 2hPG was associated with higher mortality; 2hPG added information to models with fasting glycemia and HbA1c. direct confirmation moderate

Confirmation of the evidence

Claim in the book

In the section dedicated to two-hour plasma glucose, “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi states that the OGTT evaluates the body's response to a metabolic challenge and can reveal alterations not observable while fasting. The text further argues that 2hPG possesses significant prognostic value because it integrates multiple components of glucose regulation.

Oral glucose load → coordinated response of the pancreas, liver, and peripheral tissues → 2-hour glycemia → identification of dysglycemia and increased risk of mortality

The publication subject to the Evidence Review was used in the book to support the following passage: plasma glucose measured two hours after an oral glucose load can provide prognostic information on total and cardiovascular mortality that is not completely overlapping with that of fasting glycemia and HbA1c.

The connection to “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi is therefore based on the prognostic value of 2hPG, not on the direct demonstration of every physiological mechanism described in the paragraph. The original study explicitly compares two-hour glycemia, fasting glycemia, and HbA1c in a US cohort, with total and cardiovascular mortality as outcomes. The consistency of the narrative is reinforced by independent evidence: DECODE shows that the oral test added information on the risk of death beyond categories based on fasting [1]; the Cardiovascular Health Study observes that 2hPG, but not fasting glycemia, remained associated with mortality after mutual adjustment [2]; a large Chinese cohort found that 2hPG maintained associations with mortality and other outcomes even in models including the other markers [3].

The biological chain must, however, be interpreted with caution. It is reasonable to consider 2hPG as a functional indicator of glucose management after a challenge, but prognostic studies do not quantitatively separate the contribution of beta-cell function, peripheral insulin sensitivity, and hepatic control. The evidence confirms well the association between elevated post-load glycemia and subsequent risk; it only indirectly confirms the entire mechanistic explanation proposed in the paragraph.

Overall level of confirmation

STRONG CONFIRMATION

The prognostic transition is supported by several large, independent prospective cohorts conducted in different populations with convergent results. The confirmation remains observational: it is strong regarding the association and the additional informative value of 2hPG, but it does not demonstrate causality nor the superiority of the test in every clinical context.

Conclusions

The analyzed publication pertinently supports the use of 2hPG in the book's section as a prognostic indicator of the body's response to a glucose load. Independent evidence confirms quite well that higher post-load glycemia is associated with increased mortality and higher cardiovascular risk, often beyond the information provided by fasting glycemia alone.

It is, however, necessary to distinguish this data from a complete explanation of the mechanism. 2hPG is consistent with integrated alterations in insulin secretion, insulin sensitivity, and hepatic glucose regulation, but the studies evaluated here do not directly measure all these processes. The prognostic value is well-supported; the causal implication and the choice of the most appropriate test for the individual patient require clinical evaluation and further interventional confirmation.

Overall assessment

The prognostic narrative in the paragraph is well supported by independent prospective cohorts in Europe, the United States, and China. Elevated 2hPG is associated with higher mortality and cardiovascular risk, often independently of fasting glycemia. The physiological explanation is fairly well supported on a biological level, but it is not directly demonstrated by these observational studies.

References

[1] Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1999

The Lancet

[2] Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study

Brutsaert EF, Shitole S, Biggs ML, Mukamal KJ, deBoer IH, Thacker EL, et al., 2016

The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

[3] Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults

Lu J, He J, Li M, Tang X, Hu R, Shi L, et al., 2019

Diabetes Care

Editorial note

Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.

The manuscript was also subject to independent peer review prior to publication.

To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.